![Recommendations for benefit–risk assessment methodologies and visual representations - Hughes - 2016 - Pharmacoepidemiology and Drug Safety - Wiley Online Library Recommendations for benefit–risk assessment methodologies and visual representations - Hughes - 2016 - Pharmacoepidemiology and Drug Safety - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/4174ad5d-a116-4d0e-a93e-1a31658421f1/pds3958-fig-0005-m.jpg)
Recommendations for benefit–risk assessment methodologies and visual representations - Hughes - 2016 - Pharmacoepidemiology and Drug Safety - Wiley Online Library
![PDF] A review of quantitative risk-benefit methodologies for assessing drug safety and efficacy-report of the ISPOR risk-benefit management working group. | Semantic Scholar PDF] A review of quantitative risk-benefit methodologies for assessing drug safety and efficacy-report of the ISPOR risk-benefit management working group. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/73d98ef659dc49f393c7c6b804f5734d1b300d25/6-Figure3-1.png)
PDF] A review of quantitative risk-benefit methodologies for assessing drug safety and efficacy-report of the ISPOR risk-benefit management working group. | Semantic Scholar
![Recommendations for benefit–risk assessment methodologies and visual representations - Hughes - 2016 - Pharmacoepidemiology and Drug Safety - Wiley Online Library Recommendations for benefit–risk assessment methodologies and visual representations - Hughes - 2016 - Pharmacoepidemiology and Drug Safety - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/64f1dffa-530a-4be2-a640-aebe8f309480/pds3958-fig-0001-m.jpg)